TIAM1 and esophageal squamous cell carcinoma: Past studies have found that sorafenib triggers antiproliferative and pro-apoptotic signals in human esophageal adenocarcinoma cells [290], and Tiam1 siRNA can enhance the sensitivity of sorafenib on esophageal squamous cell carcinoma in vivo [291].